Paper36978342
Antimicrobial Pharmacokinetics and Pharmacodynamics in Critical Care: Adjusting the Dose in Extracorporeal Circulation and to Prevent the Genesis of Multiresistant Bacteria.
Ruiz-Ramos J and 2 others. Antibiotics (Basel), 2023. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. Antimicrobial Pharmacokinetics and Pharmacodynamics in Critical Care: Adjusting the Dose in Extracorporeal Circulation and to Prevent the Genesis of Multiresistant Bacteria. Papers, record 36978342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36978342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antimicrobial Pharmacokinetics and Pharmacodynamics in Critical Care: Adjusting the Dose in Extracorporeal Circulation and to Prevent the Genesis of Multiresistant Bacteria.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References103
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35699444 | Using Machine Learning To Define the Impact of Beta-Lactam Early and Cumulative Target Attainment on Outcomes in Intensive Care Unit Patients with Hospital-Acquired and Ventilator-Associated Pneumonia. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/35699444 | PubMed |
| 2 | 11181370 | Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11181370 | PubMed |
| 3 | 28948652 | Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients. | J Clin Pharm Ther | 2017 | https://conductscience.org/library/papers/28948652 | PubMed |
| 4 | 12972447 | Overstretching the mutant prevention concentration. | J Antimicrob Chemother | 2003 | https://conductscience.org/library/papers/12972447 | PubMed |
| 5 | 30478168 | Multicenter Population Pharmacokinetic Study of Colistimethate Sodium and Colistin Dosed as in Normal Renal Function in Patients on Continuous Renal Replacement Therapy. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/30478168 | PubMed |
| 6 | 34041714 | Drug Clearance in Neonates: A Combination of Population Pharmacokinetic Modelling and Machine Learning Approaches to Improve Individual Prediction. | Clin Pharmacokinet | 2021 | https://conductscience.org/library/papers/34041714 | PubMed |
| 7 | 36289971 | A Systematic Review of the Effect of Therapeutic Drug Monitoring on Patient Health Outcomes during Treatment with Carbapenems. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36289971 | PubMed |
| 8 | 24768475 | Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions. | Lancet Infect Dis | 2014 | https://conductscience.org/library/papers/24768475 | PubMed |
| 9 | 35722356 | Plasma concentrations of Colistin sulfate in a patient with septic shock on extracorporeal membrane oxygenation and continuous renal replacement therapy: a case report. | Ann Transl Med | 2022 | https://conductscience.org/library/papers/35722356 | PubMed |
| 10 | 33165876 | Pharmacokinetics of ciprofloxacin during continuous renal replacement therapy in intensive care patients - new assessment. | Anaesthesiol Intensive Ther | 2020 | https://conductscience.org/library/papers/33165876 | PubMed |
| 11 | 23190792 | ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO. | BMC Anesthesiol | 2012 | https://conductscience.org/library/papers/23190792 | PubMed |
| 12 | 35023902 | Population Pharmacokinetics and Dosing Optimization of Gentamicin in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy. | Drug Des Devel Ther | 2022 | https://conductscience.org/library/papers/35023902 | PubMed |
| 13 | 24046298 | Considerations for higher doses of daptomycin in critically ill patients with methicillin-resistant Staphylococcus aureus bacteremia. | Clin Infect Dis | 2013 | https://conductscience.org/library/papers/24046298 | PubMed |
| 14 | 31325141 | What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review. | Clin Pharmacokinet | 2019 | https://conductscience.org/library/papers/31325141 | PubMed |
| 15 | 18725438 | Pharmacodynamic modeling of aminoglycosides against Pseudomonas aeruginosa and Acinetobacter baumannii: identifying dosing regimens to suppress resistance development. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18725438 | PubMed |
| 16 | 22511133 | Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. | Crit Care Med | 2012 | https://conductscience.org/library/papers/22511133 | PubMed |
| 17 | 29732181 | Optimising drug dosing in patients receiving extracorporeal membrane oxygenation. | J Thorac Dis | 2018 | https://conductscience.org/library/papers/29732181 | PubMed |
| 18 | 35631551 | Ciprofloxacin in Patients Undergoing Extracorporeal Membrane Oxygenation (ECMO): A Population Pharmacokinetic Study. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35631551 | PubMed |
| 19 | 21059616 | Pharmacokinetic-pharmacodynamic analysis of azithromycin extended release in Japanese patients with common respiratory tract infectious disease. | J Antimicrob Chemother | 2011 | https://conductscience.org/library/papers/21059616 | PubMed |
| 20 | 20862453 | Determinants of drug absorption in different ECMO circuits. | Intensive Care Med | 2010 | https://conductscience.org/library/papers/20862453 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42711757 | Prediction of the clinical outcomes of imipenem and meropenem in patients with treatment-associated AKI and death via machine learning models combined with pharmacokinetic parameters: A retrospective cohort study. | Sci Prog | 2026 | https://conductscience.org/library/papers/42711757 | PubMed |
| 42450304 | Cutaneous Staphylococcus aureus Infections in Renal Edema Across Kidney Disease and the Intensive Care Unit: Pathophysiological Mechanisms, Clinical Implications, and Therapeutic Challenges. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42450304 | PubMed |
| 42266929 | Artificial intelligence in optimizing antimicrobial therapy for gastro-renal disorders. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/42266929 | PubMed |
| 41586496 | Imipenem/cilastatin/relebactam dosing regimen justification using exposure-efficacy analyses in participants with hospital-acquired bacterial pneumonia or ventilator-associated bacterial pneumonia in the RESTORE-IMI 2 phase 3 study. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/41586496 | PubMed |
| 41510531 | Infection and antibiotic patterns in critically ill patients on extracorporeal membrane oxygenation. | Turk Gogus Kalp Damar Cerrahisi Derg | 2025 | https://conductscience.org/library/papers/41510531 | PubMed |
| 40162439 | Beta-hemolytic Streptococci in respiratory illness. | Bioinformation | 2024 | https://conductscience.org/library/papers/40162439 | PubMed |
| 39858350 | Evaluation of the Bacterial Infections and Antibiotic Prescribing Practices in the Intensive Care Unit of a Clinical Hospital in Romania. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/39858350 | PubMed |
| 39200006 | Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/39200006 | PubMed |
| 38252038 | Perspectives on the use of ceftolozane/tazobactam: a review of clinical trial data and real-world evidence. | Future Microbiol | 2024 | https://conductscience.org/library/papers/38252038 | PubMed |
| 38247631 | Translational PK/PD for the Development of Novel Antibiotics-A Drug Developer's Perspective. | Antibiotics (Basel) | 2024 | https://conductscience.org/library/papers/38247631 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CST3 | 1471 | PubTator's text mining | https://conductscience.org/library/genes/1471 | NCBI Gene |
| HMGA2 | 8091 | PubTator's text mining | https://conductscience.org/library/genes/8091 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36978342
GET https://conductscience.org/api/papers/v1/36978342/references?page=2